BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 9872245)

  • 1. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
    Laya MB; Larson EB; Taplin SH; White E
    J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cardiovascular disease, cancer and death in postmenopausal women affirming use of hormone replacement therapy.
    Hedblad B; Merlo J; Manjer J; Engström G; Berglund G; Janzon L
    Scand J Public Health; 2002; 30(1):12-9. PubMed ID: 11928828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.
    Rodriguez C; Patel AV; Calle EE; Jacob EJ; Thun MJ
    JAMA; 2001 Mar; 285(11):1460-5. PubMed ID: 11255422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.
    Willis DB; Calle EE; Miracle-McMahill HL; Heath CW
    Cancer Causes Control; 1996 Jul; 7(4):449-57. PubMed ID: 8813433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.
    Cauley JA; Seeley DG; Browner WS; Ensrud K; Kuller LH; Lipschutz RC; Hulley SB
    Arch Intern Med; 1997 Oct; 157(19):2181-7. PubMed ID: 9342994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen replacement therapy and ovarian cancer.
    Folsom AR; Anderson JP; Ross JA
    Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone therapy and mortality.
    Grodstein F; Stampfer MJ; Colditz GA; Willett WC; Manson JE; Joffe M; Rosner B; Fuchs C; Hankinson SE; Hunter DJ; Hennekens CH; Speizer FE
    N Engl J Med; 1997 Jun; 336(25):1769-75. PubMed ID: 9187066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy.
    Mikkola TS; Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4588-94. PubMed ID: 26414962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
    LeBlanc ES; Viscoli CM; Henrich JB
    J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.